Earnings Date
EPS
Quarterly Revenue
Annual Revenue (as of Sep 30)
Earnings Recap
Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Arcus Biosciences beat estimated earnings by 17.54%, reporting an EPS of $-0.94 versus an estimate of $-1.14.
Revenue was down $1.58 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 1.26% increase in the share price the next day.
Here's a look at Arcus Biosciences's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1 | -1.16 | -1.07 | -1.04 |
| EPS Actual | -1.04 | -1.09 | -0.93 | -0.90 |
| Revenue Estimate | 35.86M | 24.97M | 23.31M | 21.89M |
| Revenue Actual | 29.00M | 25.00M | 34.00M | 33.58M |
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Earnings History
Analyze the earnings history of Arcus Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2024 | PM | RCUS | Q4 | -$0.93 | — | — | — | $34.00M | — | — | — | Get Alert |
| 11/07/2023 | PM | RCUS | Q3 | -$0.90 | -$1.14 | -$0.94 | 17.54% | $33.58M | $27.28M | $32.00M | 17.30% | Get Alert |
| 08/07/2023 | AM | RCUS | Q2 | -$0.93 | -$1.00 | -$1.04 | -4.00% | $26.76M | $35.86M | $29.00M | -19.13% | Get Alert |
| 05/09/2023 | PM | RCUS | Q1 | -$0.96 | -$1.16 | -$1.09 | 6.03% | $18.00M | $24.97M | $25.00M | 0.12% | Get Alert |
| 02/28/2023 | PM | RCUS | Q4 | $3.71 | -$1.07 | -$0.93 | 13.08% | $354.50M | $23.31M | $34.00M | 45.86% | Get Alert |
| 11/02/2022 | PM | RCUS | Q3 | -$1.11 | -$1.04 | -$0.90 | 13.46% | $9.46M | $21.89M | $33.58M | 53.41% | Get Alert |
| 08/03/2022 | PM | RCUS | Q2 | -$1.09 | -$0.94 | -$0.93 | 1.06% | $9.46M | $21.12M | $26.76M | 26.70% | Get Alert |
| 05/09/2022 | PM | RCUS | Q1 | -$1.08 | -$0.31 | -$0.96 | -209.68% | $9.46M | $79.42M | $18.00M | -77.33% | Get Alert |
| 02/23/2022 | PM | RCUS | Q4 | -$0.82 | -$0.74 | $3.71 | 601.35% | $9.49M | $39.39M | $354.50M | 799.97% | Get Alert |
| 11/08/2021 | PM | RCUS | Q3 | $0.03 | -$1.08 | -$1.11 | -2.78% | $64.53M | $9.40M | $9.46M | 0.65% | Get Alert |
| 08/05/2021 | PM | RCUS | Q2 | -$0.93 | -$0.88 | -$1.09 | -23.86% | $1.75M | $13.05M | $9.46M | -27.50% | Get Alert |
| 05/05/2021 | PM | RCUS | Q1 | -$0.63 | -$0.84 | -$1.08 | -28.57% | $1.75M | $13.34M | $9.46M | -29.08% | Get Alert |
| 02/24/2021 | PM | RCUS | Q4 | -$0.38 | -$0.75 | -$0.82 | -9.33% | $9.75M | $7.93M | $9.49M | 19.63% | Get Alert |
| 11/05/2020 | PM | RCUS | Q3 | -$0.51 | $0.05 | $0.03 | -40.00% | $1.75M | $48.15M | $64.53M | 34.02% | Get Alert |
| 08/06/2020 | PM | RCUS | Q2 | -$0.64 | — | -$0.93 | — | $1.75M | — | $1.75M | — | Get Alert |
| 05/05/2020 | PM | RCUS | Q1 | -$0.41 | — | -$0.63 | — | $1.75M | — | $1.75M | — | Get Alert |
| 03/05/2020 | PM | RCUS | Q4 | -$0.28 | — | -$0.38 | — | $1.56M | — | $9.75M | — | Get Alert |
| 11/05/2019 | PM | RCUS | Q3 | -$0.25 | — | -$0.51 | — | $4.29M | — | $1.75M | — | Get Alert |
| 08/06/2019 | PM | RCUS | Q2 | -$0.32 | -$0.40 | -$0.64 | -60.00% | $1.25M | $3.35M | $1.75M | -47.76% | Get Alert |
When is Arcus Biosciences (NYSE:RCUS) reporting earnings?
Arcus Biosciences (RCUS) is scheduled to report earnings on February 27, 2024. The last reported earnings were for reported on November 7, 2023 for Q3.
What were the latest earnings per share (EPS) for Arcus Biosciences (NYSE:RCUS)?
The Actual EPS was $-0.94, which beat the estimate of $-1.14.
What were Arcus Biosciences’s (NYSE:RCUS) revenues?
The Actual Revenue was $32M, which beat the estimate of $27.3M.
Browse earnings estimates, EPS, and revenue on all stocks.